Skip to main content

Advertisement

Log in

Osteoporosis in Rheumatology

  • Review Article
  • Published:
Indian Journal of Orthopaedics Aims and scope Submit manuscript

Abstract

Introduction

Osteoporosis is a common diagnosis and comorbidity observed in patients with rheumatic diseases. It is frequently associated with conditions such as rheumatoid arthritis, spondyloarthropathy, systemic lupus erythematosus, and other autoimmune rheumatic diseases.

Conclusion

The incidence of osteoporosis is influenced by factors such as uncontrolled disease, prolonged and higher doses of steroid use, immobility, advanced age, and postmenopausal status. Achieving good control of the underlying disease, minimizing or avoiding the use of steroids for extended periods, and ensuring adequate supplementation of vitamin D and calcium are crucial in reducing the incidence of osteoporosis. Regular screening and appropriate management of osteoporosis can significantly decrease the associated morbidity and mortality.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Mattia, C., Coluzzi, F., Celidonio, L., & Vellucci, R. (2016). Bone pain mechanism in osteoporosis: A narrative review. Clinical Cases in Mineral and Bone Metabolism, 13(2), 97–100.

    PubMed  PubMed Central  Google Scholar 

  2. Sawicki, P., Tałałaj, M., Życińska, K., Zgliczyński, W. S., & Wierzba, W. (2021). Comparison of the characteristics of back pain in women with postmenopausal osteoporosis with and without vertebral compression fracture: A retrospective study at a single osteoporosis center in Poland. Medical Science Monitor, 27, e929853–e929861.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Adami, G., Fassio, A., Rossini, M., Caimmi, C., Giollo, A., Orsolini, G., et al. (2019). Osteoporosis in rheumatic diseases. International Journal of Molecular Sciences, 20(23), 5867.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Shankar, S., Handa, R., Aneja, R., Marwaha, V., Ammini, A. C., & Aprajita, V. (2009). Bone mineral density in Indian women with rheumatoid arthritis. Rheumatology International, 29(4), 377–381.

    Article  PubMed  Google Scholar 

  5. Sivaprasad, R., Gopalakrishnan, M., Khichar, S., Shukla, R., Shukla, K., & Garg, M. K. (2023). Ab0274 Effect of rheumatoid arthritis on bone mineral density and its relationship with inflammatory milieu in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases, 82(Suppl 1), 1318–1319.

    Google Scholar 

  6. McQueenie, R., Nicholl, B. I., Jani, B. D., Canning, J., Macdonald, S., McCowan, C., et al. (2020). Patterns of multimorbidity and their effects on adverse outcomes in rheumatoid arthritis: A study of 5658 UK Biobank participants. British Medical Journal Open, 10(11), e038829.

    Google Scholar 

  7. Elde, K. D., & Madsen, O. R. (2019). FRAX 10-yr fracture risk in rheumatoid arthritis—Assessments with and without bone mineral density may lead to very different results in the individual patient. Journal of Clinical Densitometry, 22(1), 31–38.

    Article  PubMed  Google Scholar 

  8. Kareem, R., Botleroo, R. A., Bhandari, R., Ogeyingbo, O. D., Ahmed, R., Gyawali, M., et al. (2021). The impact of rheumatoid arthritis on bone loss: Links to osteoporosis and osteopenia. Cureus, 13(8), e17519.

  9. Dougados, M., & Baeten, D. (2011). Spondyloarthritis. Lancet., 377(9783), 2127–2137.

    Article  PubMed  Google Scholar 

  10. Fitzgerald, G. E., & O’Shea, F. D. (2017). The fascinating paradox of osteoporosis in axial spondyloarthropathy. Journal of Rheumatology, 44(12), 1767–1776.

    Article  CAS  PubMed  Google Scholar 

  11. Klingberg, E., Lorentzon, M., Mellström, D., Geijer, M., Göthlin, J., Hilme, E., et al. (2012). Osteoporosis in ankylosing spondylitis—Prevalence, risk factors and methods of assessment. Arthritis Research & Therapy, 14(3), R108.

    Article  Google Scholar 

  12. Lim, M. J., & Kang, K. Y. (2020). A contemporary view of the diagnosis of osteoporosis in patients with axial spondyloarthritis. Frontiers in Medicine, 11(7), 569449.

    Article  Google Scholar 

  13. van der Weijden, M. A. C., Claushuis, T. A. M., Nazari, T., Lems, W. F., Dijkmans, B. A. C., & van der Horst-Bruinsma, I. E. (2012). High prevalence of low bone mineral density in patients within 10 years of onset of ankylosing spondylitis: A systematic review. Clinical Rheumatology, 31(11), 1529–1535.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Fitzgerald, G. E., O’Dwyer, T., Mockler, D., O’Shea, F. D., & Wilson, F. (2020). Pharmacological treatment for managing bone health in axial spondyloarthropathy: Systematic review and meta-analysis. Rheumatology International, 40(9), 1369–1384.

    Article  PubMed  Google Scholar 

  15. Hinze, A. M., & Louie, G. H. (2016). Osteoporosis management in ankylosing spondylitis. Curr Treatm Opt Rheumatol., 2(4), 271–282.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Viapiana, O., Gatti, D., Idolazzi, L., Fracassi, E., Adami, S., Troplini, S., et al. (2014). Bisphosphonates vs infliximab in ankylosing spondylitis treatment. Rheumatology, 53(1), 90–94.

    Article  CAS  PubMed  Google Scholar 

  17. Mok, C., Li, O., Chan, K., Ho, L., & Hui, P. (2015). Effect of golimumab and pamidronate on clinical efficacy and MRI inflammation in axial spondyloarthritis: A 48-week open randomized trial. Scandinavian Journal of Rheumatology, 44(6), 480–486.

    Article  CAS  PubMed  Google Scholar 

  18. Wabl, M. (2010). The 9th International Congress on SLE. SAGE, 19, 1.

    Google Scholar 

  19. Sun, Y. N., Feng, X. Y., He, L., Zeng, L. X., Hao, Z. M., Lv, X. H., et al. (2015). Prevalence and possible risk factors of low bone mineral density in untreated female patients with systemic lupus erythematosus. BioMed Research International, 8(2015), e510514.

    Google Scholar 

  20. The Writing Group for the ISCD Position Development Conference. (2004). Diagnosis of osteoporosis in men, premenopausal women, and children. Journal of Clinical Densitometry 7(1):17–26.

Download references

Funding

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chandrashekara S..

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical standard statement

This article does not contain any studies with human or animal subjects performed by the any of the authors.

Informed consent

For this type of study informed consent is not required.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chandrashekara, S. Osteoporosis in Rheumatology. JOIO 57 (Suppl 1), 176–180 (2023). https://doi.org/10.1007/s43465-023-01024-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s43465-023-01024-z

Keywords

Navigation